Skip to main content
TRT
PROVIDER
GUIDE
RESOURCE

Does UnitedHealthcare Cover TRT? What UHC Actually Requires in 2026

Identify your exact UHC plan, drug list and benefit, then compare published authorization criteria, separate care costs and the records to check before paying.

Educational resource
Evidence Cited

By TRT Provider Guide · Last verified: October 2026 (sources checked October 22, 2026) · Editorial research from public sources; not clinically reviewed · Educational information, not medical advice or a personal coverage decision

Last updated: .

Does UnitedHealthcare cover TRT (testosterone replacement therapy)? Yes, when your plan covers the product and the applicable criteria are met. Its September 2026 commercial drug list puts generic injections in Tier 1 with no prior-authorization flag; listed gels and Kyzatrex need approval. Your exact plan, product and benefit determine the rules.

Best for: UHC members checking testosterone coverage, comparing full costs, or preparing a request or appeal for adult male hypogonadism.

Not for you if: you need a diagnosis or a policy for another purpose, such as gender-affirming care. Those need their own clinical evaluation and coverage pathway.

That's the short answer. The longer one decides whether your prescription goes through on the first try, or bounces back with "prior authorization required."

We read UnitedHealthcare's own 2026 testosterone documents, page by page: its drug list, its pharmacy prior-authorization program, its medical policy and its lab-billing rule. A request can also fail because of a missing date, a medication on the list, or a qualifying finding that never made it into the visit note. We'll show you each one.

Four things can change your answer:

  • Your plan type. Employer plans, Individual & Family plans, AARP Medicare Advantage and UHC Community Plan (Medicaid) each follow their own drug list.
  • Your plan's drug list. Some UHC employer lists require prior authorization even for generic injections.
  • Which benefit is billed. Testosterone billed under the medical benefit follows the applicable medical policy. A prescription billed under the pharmacy benefit follows your pharmacy drug list.
  • Your fertility plans. Testosterone can lower sperm production. Say so before you start.

The 10-second version

UnitedHealthcare testosterone coverage table 1: The 10-second version
If your doctor prescribes… Published UHC commercial drug list (Sept. 1, 2026) or cited pharmacy/medical policy
Generic testosterone cypionate or enanthate injection Tier 1, no prior-authorization flag*
Testosterone 1.62% gel or Testim Tier 2, prior authorization required
Testosterone gel 12.5 mg/act (1%) Tier 4, prior authorization required
Kyzatrex (oral capsule) Tier 4, prior authorization required
Xyosted (autoinjector) Prior authorization; the initial hypogonadism pathways require failure, contraindication or intolerance to specified injections and gels
Testopel pellets or Aveed, billed under the medical benefit Applicable medical policy criteria apply
Compounded testosterone (creams, troches, compounded pellets) Treated as unproven by UHC's Commercial medical-benefit policy

*This is a published example, not every member's drug list. Your plan's benefit terms and current list control. Here's how to check yours.

Sources: UHC's September 2026 drug list, pharmacy authorization program and Commercial medical-benefit policy.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

Want to walk into your appointment ready? Jump to the UHC paperwork checklist and bring it to your doctor.

The right path depends on you. The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to explore general online-care options and prepare questions before you pay. The tool is educational. It does not diagnose low testosterone or confirm your UHC benefits.

Does UnitedHealthcare cover TRT, and which testosterone is easiest to get covered?

UnitedHealthcare can cover FDA-approved testosterone for men diagnosed with hypogonadism, but coverage depends on the plan, exact product and benefit billed. In UHC's published commercial Prescription Drug List (effective September 1, 2026), generic testosterone cypionate and enanthate injections are Tier 1 with no prior-authorization flag. The listed gels, Testim and the oral capsule Kyzatrex need prior authorization.

First, a few words you'll see on every insurance page:

  • Hypogonadism means your body doesn't make enough testosterone. Doctors diagnose it from symptoms plus repeat blood tests, not from one number.
  • Prior authorization (PA) means your doctor has to send proof to UHC before UHC will pay.
  • Tier is the price level on the drug list. Tier 1 is usually the cheapest for you.
  • Quantity limit (QL) caps how much UHC covers per fill.
  • Step therapy means the plan requires a preferred option first, unless its exception rules are met.
  • FDA-approved products went through FDA review for safety and effectiveness. Compounded testosterone is prepared by a pharmacy or other compounder and is not FDA-approved.

The UHC testosterone coverage map

This is the core of the page. We built it from four UnitedHealthcare and Optum documents. The medical-benefit rows summarize Commercial policy 2026D0076J; check your plan's benefit and review requirements.

UnitedHealthcare testosterone coverage table 2: The UHC testosterone coverage map
Product How you get it UHC tier (Sept. 2026 drug list) Prior authorization? Extra hurdle Which UHC document to check FDA status
Generic testosterone cypionate Pharmacy (self-injected) Tier 1 No flag on this published list. Some employer lists require it (example below). Your plan's list decides Your drug list FDA-approved generic
Generic testosterone enanthate Pharmacy (self-injected) Tier 1 Same as above Your plan's list decides Your drug list FDA-approved generic
Testosterone gel 1.62% (generic AndroGel 1.62%) Pharmacy Tier 2 Yes Lab, medication and symptom rules in the lab-based pathway; quantity limit Pharmacy PA program FDA-approved generic
Testosterone gel 12.5 mg/act (1%) Pharmacy Tier 4 Yes Quantity limit; check the exact presentation Pharmacy PA program FDA-approved generic
Testim Pharmacy Tier 2 Yes Quantity limit Pharmacy PA program FDA-approved
Kyzatrex (oral) Pharmacy Tier 4 Yes Quantity limit Pharmacy PA program FDA-approved
Jatenzo, Tlando, Undecatrex, Natesto, Vogelxo Pharmacy Not listed in this published PDL Yes, if covered UHC marks them "may be excluded from coverage" Pharmacy PA program FDA-approved
Xyosted (autoinjector) Pharmacy Not listed in this published PDL Yes Initial hypogonadism approval: failure, contraindication or intolerance to both generic injections and both 1.62% gel and Testim Pharmacy PA program FDA-approved
Cypionate or enanthate billed under the medical benefit Medical benefit n/a Check plan's review requirements Dosing must follow FDA labeling Medical policy 2026D0076J FDA-approved
Testopel (pellets) Medical benefit, implanted in office n/a Check plan's review requirements Same diagnosis-specific criteria as the listed injections Medical policy 2026D0076J FDA-approved
Aveed (testosterone undecanoate injection) Medical benefit, in office n/a Check plan's review requirements Given in a clinic under an FDA safety program Medical policy 2026D0076J FDA-approved
Azmiro (testosterone cypionate) Medical benefit n/a — UHC's Commercial policy says it is "typically excluded"; law or plan terms may allow review Medical policy 2026D0076J FDA-approved; FDA lists its marketing status as discontinued
Compounded testosterone (creams, troches, compounded pellets) Compounding pharmacy or cash clinic Not listed — UHC's Commercial medical-benefit policy says compounded hormone products are not proven or medically necessary for any indication Medical policy 2026D0076J Not FDA-approved

Sources: UHC Prescription Drug List, effective Sept. 1, 2026; UHC Prior Authorization/Medical Necessity – Testosterone, program 2025 P 2018-19, effective Feb. 1, 2026; UHC Medical Benefit Drug Policy 2026D0076J, effective Jan. 1, 2026; Optum Rx Premium Formulary PA list, Jan. 1, 2026. Checked October 22, 2026.

FDA status checked against FDA records for cypionate, enanthate, 1.62% gel, 1% metered gel, Testim, Kyzatrex, Jatenzo, Tlando, Natesto, Vogelxo, Xyosted, Testopel, Aveed and Azmiro, plus Undecatrex's authorized-generic listing. FDA approval and a plan listing do not establish pharmacy stock.

Three fine-print rules that matter:

  1. The list isn't your contract. UHC's drug list says plainly that it "does not define benefit coverage." Your plan document does.
  2. Same insurer, different lists. The January 1, 2026 Optum Rx Premium PA list includes cypionate and enanthate injections. Its limits are package-specific: one 10 mL cypionate vial per 28 days, a separate cypionate 200 mg/mL entry allowing four 1 mL vials per 28 days, and one 5 mL enanthate 200 mg/mL vial per 28 days. These are payment limits, not dosing advice. UHC's January 2026 commercial list also marked some testosterone-gel presentations as excluded. That's why two UHC members can get two different answers.
  3. Connecticut, New Jersey and New York: this UHC drug list says drugs marked excluded or step therapy are subject to prior authorization in these states. That does not guarantee coverage.

Injections: the path of least paperwork

If your plan uses this published list, a generic testosterone injection has fewer listed authorization hurdles than the gels and Kyzatrex. It's Tier 1, and the pharmacy PA program doesn't list it. Your plan may still set quantity limits.

Getting the same drug billed under the medical benefit is different. Then the applicable UHC medical policy applies, with its own lab rules. More on that in the requirements section below.

Gels and topical testosterone

The gels listed in the September commercial PDL need prior authorization. Other UHC lists use different restrictions. The listed generic 1.62% gels sit in a lower tier than the 12.5 mg/act 1% gel on this list. Your plan decides the actual cost. Gels can rub off on partners and kids through skin contact, as the FDA label warns. That's a real safety issue, and we cover it in our guide to testosterone cream transfer risk.

Oral testosterone

Kyzatrex is on this published list at Tier 4 with prior authorization. Jatenzo, Tlando and Undecatrex are in UHC's PA program but marked "may be excluded." If your doctor wants one of those, ask about a formulary exception. Costs vary a lot, so ask for separate quotes for Kyzatrex, Jatenzo and other oral products your clinician is considering.

Xyosted

Xyosted has the steepest climb. Under the program effective February 1, 2026, following its November 2025 update, UHC's initial hypogonadism pathways require a documented failure, contraindication (a medical reason you can't use it) or intolerance for four products: both generic injections, generic 1.62% gel and Testim. Ask for a quote for the exact Xyosted prescription.

Pellets and Aveed

FDA-approved Testopel pellets and Aveed injections are included in UHC's Commercial medical-benefit policy, with the same diagnosis-specific criteria as the other injections it lists. UHC's medical policy notes that Testopel's safety and effectiveness in age-related hypogonadism haven't been established. Aveed must be given in a certified healthcare setting under its FDA safety program, with observation for 30 minutes after each injection. Ask for separate drug and administration or insertion charges. Our treatment-format guide explains how these options differ.

Compounded testosterone

Here's the distinction that changes what you're paying for. UHC's Commercial medical-benefit policy says compounded hormone products, "including but not limited to compounded testosterone," are not proven or medically necessary for any indication. It also notes they are not FDA-approved. Under this Commercial medical-benefit policy, compounded hormones do not meet UHC's medical-necessity standard. Pharmacy coverage needs a separate plan check.

Not sure which format, or whether insurance or cash, fits you? That depends on your labs, health history, fertility plans and budget. Explore general online-care options with Find My TRT Path.

Does it matter which UnitedHealthcare plan you have?

Yes. Employer plans, Individual & Family (marketplace) plans, Medicare Advantage and UHC Community Plan (Medicaid) each use their own drug list and policy, so the same prescription can be easy on one UHC plan and blocked on another. Find your plan type on your ID card before you trust any general answer, including ours.

UnitedHealthcare testosterone coverage table 3: Does it matter which UnitedHealthcare plan you have?
Your card says… What decides testosterone coverage Where to check What we found (Oct. 2026)
UnitedHealthcare employer plan (also Surest, Level Funded, Oxford, River Valley and others) Your plan's drug list and the pharmacy and medical policies that apply to it myuhc.com, the UHC app, or the number on your card Lists differ. The January 2026 commercial list contained both Tier 2 gel entries with PA and excluded gel entries. Check the current list for your exact product.
An Optum Rx card with an employer-specific formulary That formulary optumrx.com The January 2026 Premium PA list includes generic injections; check your current benefit rules.
UnitedHealthcare Individual & Family (ACA marketplace) Exchange policy IEXD0076.07, plus your marketplace drug list Your plan documents The policy doesn't apply in Massachusetts, Nevada or New York. For Medical Necessity Plans, it adds "preferred product" rules before UHC covers a non-preferred testosterone.
AARP Medicare Advantage from UHC, UHC Medicare Advantage, or an AARP Medicare Rx (Part D) plan Your plan's formulary and Medicare rules myAARPMedicare.com The NC-13/NC-14 example formulary lists testosterone gel, cypionate and enanthate. Tier and PA vary by plan.
AARP Medicare Supplement (Medigap) Original Medicare, plus any separate Part D plan Medicare.gov Medigap plans sold after 2005 don't include drug coverage. The commercial list above doesn't apply.
UnitedHealthcare Community Plan (Medicaid) Applicable state rules, your state's drug list, and policy CS2026D0076Q (effective July 1, 2026) where it applies Your state's Community Plan drug list Several states use their own Medicaid rules. Drug lists differ by state.

Medicare Advantage and Part D

The 2026 AARP Medicare Advantage NC-13/NC-14 example formulary lists generic testosterone products. Your tier and any prior authorization depend on your exact plan. Some testosterone can fall under Part B or Part D; the product, how it is supplied and administered, and Medicare's rules determine which benefit to check. Ask your plan which part would pay for your exact prescription and how the billing would work. Medicare's outpatient-drug coverage page explains the Part B boundary.

UHC Community Plan (Medicaid)

Medicaid coverage depends on your state. UHC's Community Plan policy has state-specific exceptions. Indiana, Kansas and Pennsylvania use state Medicaid criteria, and Ohio has its own policy. Arizona and Texas use drug-specific state criteria when available; otherwise, this policy applies. Check the policy's full state table for other exceptions. Even where UHC's policy applies, the state drug lists differ. Here are two Community Plan lists dated October 1, 2026:

UnitedHealthcare testosterone coverage table 4: UHC Community Plan (Medicaid)
State Generic cypionate 100 mg/mL Generic cypionate 200 mg/mL Generic enanthate
Maryland Tier 1, quantity limit, age limit Tier 1, diagnosis required, quantity limit, age limit Tier 1, non-preferred, prior authorization, quantity limit, age limit
Rhode Island Tier 1, quantity limit Tier 1, prior authorization, quantity limit Tier 1

Sources: UHC Community Plan preferred drug lists for Maryland and Rhode Island, effective Oct. 1, 2026. Strengths identify products. They are not dosing advice.

An age-limit flag means the plan restricts coverage by age; check the actual age rule rather than inferring it from the flag.

Same drug, same insurer, different states, different rules. That's the whole case for checking your own list.

What does UnitedHealthcare require for testosterone prior authorization?

For its lab-based hypogonadism pathway, UHC's pharmacy program requires low pretreatment results, a diagnosis, a listed symptom or cause, and medication checks. The program also has an SHBG-related testing alternative and separate pathways for specified medical histories, with 12-month approvals. The Commercial medical-benefit policy has a two-total-test pathway that specifies early-morning blood draws, alongside alternative pathways.

Two terms first:

  • Total testosterone is all the testosterone in your blood.
  • Free testosterone is the small share not attached to proteins. SHBG (sex hormone-binding globulin) is the main protein that holds onto testosterone. Some conditions push SHBG up or down, which can make total testosterone misleading.

UHC's five rules, decoded

Here's what the lab-based hypogonadism pathway in UHC's pharmacy program (2025 P 2018-19, effective Feb. 1, 2026) asks for, followed by the renewal rules. The specified-history alternatives below are different. Read the full UHC pharmacy program. This program names topical and oral products and Xyosted; do not apply it automatically to generic cypionate or enanthate injections.

UnitedHealthcare testosterone coverage table 5: UHC's five rules, decoded
UHC's rule What it means What your doctor documents What to check in the submission
1. Two low results before treatment. Total testosterone under 300 ng/dL or below the lab's reference range, taken at separate times, with the value and date of each Two separate low pretreatment results, documented with their dates Both lab reports, with dates and the lab's printed range Only one test, no dates, or tests drawn while already on testosterone
1b. The SHBG exception. If you have a condition that can change SHBG (thyroid disorder, HIV, liver disorder, diabetes or obesity): one pretreatment calculated free or bioavailable testosterone result under 50 pg/mL or below the lab's range With one of those conditions, one qualifying pretreatment calculated free or bioavailable result can stand in The condition on your chart, plus the calculated free or bioavailable result The condition isn't documented
2. No aromatase inhibitor or one of the listed growth hormones in this branch. The growth-hormone exception is panhypopituitarism (low output from several pituitary hormones) Current aromatase-inhibitor use conflicts with this branch's medication rule Your current medication list Current use of an aromatase inhibitor, or a listed growth hormone without the exception
3. Male at birth, plus a diagnosis of hypogonadism A documented diagnosis of hypogonadism, not just an unexplained low result A diagnosis such as testicular hypofunction A vague or missing diagnosis
4. One reason from UHC's list: significant weight loss to less than 90% of ideal body weight (such as wasting), osteopenia, osteoporosis, decreased bone density, decreased libido, or an organic cause (injury, tumor, infection or a genetic defect) Fatigue, brain fog and low energy are not on the list by themselves The finding, written in the visit note The note only says "tired"
5. Approval length and renewal. 12 months. Renewal has a specified-medical-history pathway or a recent-lab pathway The lab pathway accepts total testosterone, or calculated free/bioavailable testosterone with an SHBG-related condition, from the past 12 months. Results must be within or below the lab's normal male range, or above it with a documented dose adjustment; medication conditions still apply The record required by the applicable renewal pathway A high level with no dose change on record

Specified-history paths: The initial topical/oral pathway separately accepts both testicles having been removed (bilateral orchiectomy), panhypopituitarism, or a genetic cause such as Klinefelter syndrome in a patient who was male at birth. For Xyosted, that history pathway also requires the four-product history. Plan coverage restrictions still apply.

The listed growth hormones are Genotropin, Humatrope, Norditropin FlexPro, Nutropin AQ, Omnitrope and Saizen.

Auto-approval: UHC says it "may approve" requests based only on claims history, diagnosis codes or claim logic. Don't count on it.

Rule 2 can block an otherwise complete lab-based request

If anastrozole (an estrogen blocker) is on your current medication list, flag it before the request. UHC's lab-based initial-authorization pathway excludes current aromatase-inhibitor use for a gel, oral capsule or Xyosted; its specified-history pathways are different.

Don't stop or change any medication on your own. Tell the prescriber about UHC's rule and let them decide. Our page on TRT and estradiol levels explains why some clinics prescribe it and what to ask about its role in your care.

Rule 4: tell your doctor everything you actually feel

UHC's list of qualifying reasons is short. "Decreased libido" is on it. "Tired all the time" is not, at least not by itself. If you have low sex drive, low bone density or another listed finding, it needs to be in the visit note.

Just as important: never claim a symptom you don't have. Ask the office to correct any mistake in your record. More on this in our guide to TRT and low libido.

Medical-benefit injections and pellets: slightly different rules

UHC's Commercial medical-benefit policy (2026D0076J) sets criteria for the injections and pellets it lists. It differs from the pharmacy program in four ways (UHC policy):

  • In the two-total-test pathway, the two pre-treatment results must be early-morning draws.
  • It has a separate path for men already on testosterone. A recent calculated free or bioavailable testosterone result can count: within 6 months if you've been on therapy under a year, or 12 months if a year or longer. The result must be in or below the lab's normal male range, or above it with a documented dose change.
  • Dosing must follow FDA labeling.
  • It does not list the aromatase-inhibitor rule or the symptom list.

Insurance rules vs. a medical diagnosis

UHC's rules decide payment. They don't diagnose anyone. The Endocrine Society's guideline calls for symptoms or signs of testosterone deficiency plus consistently low testosterone, confirmed with repeat morning, fasting blood tests. That's why your doctor will usually test in the morning, even where UHC's pharmacy rule only says "separate times." Our guide on how low testosterone is diagnosed goes deeper into the evaluation and why repeat testing matters.

Four coverage claims to check

We checked these claims against UHC's 2026 documents:

UnitedHealthcare testosterone coverage table 6: Four coverage claims to check
Claim to check What UHC's documents say
A published insurer approval percentage predicts my result. We found no UHC-published TRT approval-rate dataset in the documents reviewed. Written criteria do not predict an individual decision.
Your labs must be drawn between 8 and 10 a.m. UHC's medical policy says "early morning." The pharmacy program says "separate times." Neither sets a clock window. (Medical guidelines do call for morning testing.)
Hematocrit must be under 54% and PSA normal to qualify. Neither appears in UHC's 2026 testosterone PA criteria. Your doctor may still check them for safety.
You must be under 300 ng/dL. The two-total-test pathway accepts under 300 or below your lab's reference range. Other evidence pathways exist; a number alone does not diagnose hypogonadism.

Ready to prep your request? Take the UHC paperwork checklist to your doctor. It organizes key paperwork by policy name; your prescriber should check the full criteria that apply.

Already on TRT? How to switch to UHC coverage

A major UHC hurdle for men already on testosterone is the "before treatment" lab requirement. UHC's pharmacy program says getting two pre-treatment results "may require treatment to be temporarily held." Any treatment pause must be planned with your clinician.

If you kept your original lab reports from before you started, they're the most valuable paperwork you own.

This is a documentation issue to resolve before switching from a cash clinic. Here's how to handle it:

  1. Find your pre-TRT labs. Check your old clinic's patient portal, your Quest or Labcorp account, or results from an earlier physical. You need dated reports with the lab's reference range.
  2. Ask which path applies. For medical-benefit treatment, UHC's Commercial policy has a "currently on therapy" path. Ask your new doctor whether your request will be reviewed as a new start or a continuation.
  3. Bring your full med list. If anastrozole is on it, ask whether the applicable pharmacy pathway includes Rule 2. Let the prescriber decide what to do. Don't change it yourself.
  4. Discuss any product change. If your clinic used compounded cream, ask your new doctor which formulation and coverage pathway fit your care. An FDA-approved product is a separate option, not an automatic substitute for the compounded preparation. Doses don't swap one-for-one.
  5. Don't stop testosterone on your own to "re-test." Ask your clinician how to handle any interruption. Any pause belongs under a clinician's care. See can you stop TRT?

Does UHC cover TRT bloodwork?

UHC can cover TRT bloodwork, but lab bills follow a separate reimbursement policy and your plan's benefits. The 2026 Commercial and Individual & Family policy limits total testosterone testing during TRT to once every 60 days, and excludes total, free or bioavailable testosterone testing for people with no symptoms or only "non-specific" symptoms. These limits do not guarantee payment.

This rule took effect in 2026. UHC's lab policy 2026R8020A ("Testosterone Policy, Professional and Facility") sets payment limits for testosterone testing:

UnitedHealthcare testosterone coverage table 7: Does UHC cover TRT bloodwork?
Test Published reimbursement limits (Commercial & Individual & Family plans)
Total testosterone to check for low testosterone in men One test per day, for no more than two consecutive calendar days, as the first screening. If results are normal and symptoms continue, a follow-up no sooner than 60 days later.
Total testosterone during TRT No more than once every 60 days
Free testosterone, SHBG and albumin Once every 365 days for men with hypogonadism, gynecomastia or other testicular hypofunction
Bioavailable testosterone When a disorder that raises or lowers SHBG is suspected
Estradiol Once per lifetime, before testosterone therapy, in men with gynecomastia (enlarged breast tissue)
Total, free or bioavailable testosterone tests ordered for no symptoms or "non-specific" symptoms Not reimbursed under this policy

Source: UHC Testosterone Policy 2026R8020A. Limits apply separately by billing code and do not guarantee coverage. General implementation was September 1, 2026. October 1 exceptions were Arkansas, Colorado, Kentucky, North Carolina, Nebraska, Ohio and Rhode Island for Commercial plans; Colorado, North Carolina, Nebraska and Ohio for Individual & Family plans. See the Commercial bulletin and Individual & Family bulletin.

What this means for you:

  • These are payment rules, not a monitoring schedule. Your doctor decides how often you need labs. UHC decides how often it pays.
  • The visit note matters for labs too. For the listed testosterone tests, the documented reason for testing affects reimbursement.
  • Ask before the draw. Ask whether the lab is in network and what you'll owe. Ask your clinician which diagnostic and monitoring tests your care requires.

How much will TRT cost with UnitedHealthcare?

With UHC, a Tier 1 generic injection uses your plan's Tier 1 cost sharing; visits and labs may have separate copays, coinsurance or deductibles. Cash prices also depend on the exact product, package and pharmacy. Compare your copay and the full cost of care before paying either way.

There's no single "UHC TRT price." Your cost depends on your plan's tier copays, your deductible and your coinsurance. Three quick definitions:

  • Deductible: what you pay before your plan starts sharing costs for certain services.
  • Copay: a flat amount per fill or visit.
  • Coinsurance: a percentage of the allowed charge.

Here's what the main paths look like side by side:

UnitedHealthcare testosterone coverage table 8: How much will TRT cost with UnitedHealthcare?
Path What you pay What's FDA-approved? Notes
UHC, generic injection (Tier 1) Your plan's Tier 1 cost sharing, plus visits and labs Yes Compare your plan's complete quote with the cash alternatives
Cash with a discount coupon, generic cypionate $18.98 standard GoodRx coupon example: one 1 mL vial, 200 mg/mL, Hy-Vee, ZIP 50307; checked Oct. 22, 2026, coupon marked updated Oct. 21 Yes You still need a prescriber, visits and labs
Cash online program (example: Male Excel) $99 startup consultation/test + $99/month membership + advertised injectable testosterone-and-thyroid bundle from $120/month, plus shipping No (compounded testosterone) Provider-stated, Oct. 22, 2026. Details in the cash-route section below.

The GoodRx example is a dated coupon quote, not a guaranteed price or a month's supply. Prices vary, and applicable tax is extra.

Our take: If your labs and chart meet UHC's rules, compare your in-network generic-injection estimate before paying for a cash program. Cash programs may bundle clinician access and monitoring. A higher program price does not establish a better drug.

Build your first-year cost estimate

Fill this in with real quotes from UHC, your pharmacy and your doctor's office. Don't guess.

UnitedHealthcare testosterone coverage table 9: Build your first-year cost estimate
Cost item Ask for Times in 12 months Your total
First evaluation visit(s) Your share per visit ___ ___
Diagnostic labs (the tests your clinician orders) Your share for the actual tests ___ ___
Follow-up visits Your share per visit ___ ___
Monitoring labs Your share per set ___ ___
Medication Your share for the exact product, quantity and fill period ___ ___
In-office shot or pellet procedure (if any) Separate drug and procedure charges ___ ___
Supplies, shipping or membership fees Any charge not billed to UHC ___ ___
First-year total ___

Two tips:

  • Don't double-count the deductible. If your visit quotes already include it, don't add it again.
  • Compare the same things. A cash quote that leaves out labs isn't cheaper just because it's smaller. Our TRT cost guide explains the charges to compare.

How do I check my own UHC testosterone coverage?

Look up the exact drug and strength in your UHC member account or app, or call the number on your ID card. Ask whether it's on your drug list, whether it needs prior authorization, step therapy or a quantity exception, and which benefit pays for it. Write down the date and a reference number.

Your coverage check

  1. Find your plan name on your ID card, and note whether your drug benefit runs through Optum Rx.
  2. Sign in to myuhc.com, myAARPMedicare.com or the UHC app.
  3. Search the exact drug and strength, like "testosterone cypionate 200 mg/mL." Don't just type "testosterone."
  4. Write down the tier and any PA, QL (quantity limit) or ST (step therapy) mark.
  5. Screenshot it for your doctor. Prescribers can check pharmacy coverage and estimated cost through UHC's PreCheck MyScript tool. Ask them to.

Look up your drug now: Open UHC's prescription drug lists and sign in to see the list your plan uses.

What to say when you call UHC

Copy this to organize the questions and get answers you can act on:

"I'm checking my benefits before I pay for care. My doctor is considering [exact product and strength]. Is it covered under my pharmacy benefit or my medical benefit? Is it on my plan's current drug list? Does it need prior authorization, step therapy or a quantity exception?

Which policy applies, and can you send it to me? What changes if this is continuing treatment rather than a new start?

What would I owe for the medication, the visits and the lab tests? Does that include my remaining deductible?

If approval is needed, who submits it, where does it go, and how do we confirm it was received? What's my reference number for this call?"

That last question matters more than it sounds. One snag to check: the office says it sent the request, and UHC says it never arrived. Get a confirmation either way.

The UHC testosterone paperwork checklist

Bring this to your appointment. Use it to prepare the records for the policy branch that applies to you.

For your doctor's office (pharmacy PA requests: gels, oral capsules, Xyosted):

  • Ask whether the specified-history or renewal pathway applies instead of the initial lab-based pathway
  • Confirm that the requested product is covered or that a formulary exception can be requested
  • The exact product requested, and the policy name: UHC Prior Authorization/Medical Necessity – Testosterone (2025 P 2018-19)
  • For the two-total-test pathway: two pre-treatment reports, each with value, date and the lab's reference range
  • Or, if an SHBG-related condition applies: one pre-treatment calculated free or bioavailable testosterone report, with value, date and lab range, plus the condition documented
  • A hypogonadism diagnosis on the chart
  • At least one listed reason documented: decreased libido, osteopenia or osteoporosis, low bone density, significant weight loss to less than 90% of ideal body weight, or an organic cause
  • A current medication list (note any aromatase inhibitor or growth hormone)
  • For Xyosted: the history with both generic injections, 1.62% gel and Testim
  • Who submits, where it goes, and how receipt will be confirmed

For a request under UHC Commercial Medical Benefit Drug Policy 2026D0076J: ask which evidence pathway applies. For the two-total-test pathway, include reports documenting the actual early-morning collection times. If you're already on therapy, the policy has a separate pathway using a recent calculated free or bioavailable testosterone result.

Your record: date checked · plan name · drug list name · product and strength · tier and marks · reference number · decision and approval-through date.

This checklist organizes paperwork. It doesn't tell anyone to order tests, change a diagnosis or alter a record.

UHC denied my testosterone. What now?

Documentation problems that can affect a request include one lab result instead of two, missing dates, labs drawn while already on testosterone, no listed reason in the chart, or a medication that conflicts with the applicable pathway. First, figure out whether the request is missing, pending, formally denied, or approved with a billing glitch. Then address the written reason, ask for an exception, or appeal.

A denial feels personal. Read the written reason: missing records, product restrictions and benefit exclusions need different responses.

Match what you were told to the next step

UnitedHealthcare testosterone coverage table 10: Match what you were told to the next step
What you were told What to find out Who to involve
"Prior authorization needed" at the pharmacy Was a request actually sent, and to the right place (UHC or Optum Rx)? Doctor's office, pharmacy
"Pending" or "more information needed" Exactly what's missing, who sends it, and by when Doctor's office
"Not covered" or "non-formulary" Is it excluded from your plan, or does UHC want you to try a preferred drug first? Doctor, UHC
Written denial The reason, the policy used, and the deadline to respond You and your doctor
Approved, but the pharmacy still rejects it Do the product, strength, quantity and dates match the approval? Pharmacy, UHC
Approved, but expensive Your tier, deductible and coinsurance. Approval isn't a price. UHC, pharmacy
Lab bill denied The specific claim and reason. Lab denials follow the lab billing rules, not the prescription appeal process. Lab, doctor's billing office, UHC

Common denial reasons and fixes

UnitedHealthcare testosterone coverage table 11: Common denial reasons and fixes
Denial reason Usual fix
Only one low result Send the second dated report, or ask your prescriber whether repeat morning testing or another evidence pathway applies
Results drawn while on testosterone Send pre-treatment reports, or ask about the "currently on therapy" path in the Commercial medical-benefit policy
No qualifying reason documented Your doctor updates the note with findings you actually have
Aromatase inhibitor on the med list The prescriber reviews it. You don't change it yourself.
Product not preferred or excluded Ask your prescriber about a covered product or a formulary exception with a medical reason
Xyosted step therapy not met Document the history with all four required products

Your appeal rights

  • Employer and marketplace plans: Your denial letter lists your deadline. Federal internal-appeal protections generally provide at least 180 days after you receive the denial notice. For plans governed by the federal employee-benefit claims rule, a pre-service appeal has a 30-day deadline when there is one required appeal level, or 15 days at each of two levels; urgent appeals have a 72-hour limit. External review may be available after an unsuccessful internal appeal. Follow the process for your plan and claim (HealthCare.gov; federal claims rule).
  • UHC Medicare Part D: You have 65 days from the date the unfavorable decision was issued to request an appeal; a late request may be accepted for good cause. For a drug you have not received, UHC lists 7 days for a standard appeal and 72 hours for an expedited appeal. A reimbursement appeal for a drug you already received has a 14-day decision period (UHC Medicare).
  • Urgent means urgent. Ask for an expedited review only if waiting could seriously harm your health. Your doctor can tell you if that applies.
  • A status call may not file an appeal. Follow your denial notice's instructions and confirm your appeal was received; some processes accept an appeal by phone.

Have a written denial? Find your plan's appeal forms on UHC's member forms page. For a step-by-step appeal walkthrough and letter outline, see our testosterone prior authorization guide.

Can you use UnitedHealthcare with an online TRT clinic?

It depends on the clinic and your exact plan: online care does not itself decide insurance coverage. Male Excel and Hone describe their clinical services as self-pay, but their prescription-billing arrangements differ. If you want UHC to pay, confirm a clinician's network status and the product, visit and lab benefits before you enroll.

Before you enroll anywhere, ask four questions:

  1. Are you in network for my exact UHC plan?
  2. Do you bill UHC for visits, or just give me a receipt?
  3. Who bills the labs and the medication?
  4. Is the testosterone FDA-approved or compounded?

A few online and local clinics say they work with insurance. Our guide to TRT providers that take insurance sorts out who actually bills and who doesn't. A clinic that "takes UHC" still doesn't settle the drug or lab bill. Those follow the rules above. Our online-vs-local care guide compares the care settings.

About online prescribing: Testosterone is a Schedule III controlled substance; pharmacy dispensing requires a valid prescription under federal prescription rules, and controlled-substance rules apply. The DEA has extended telemedicine flexibilities through December 31, 2026. Until then, DEA-registered clinicians may prescribe Schedule II–V drugs over video without a prior in-person visit, if federal and state law are met. Check the current rules before arranging care after that date. None of this guarantees a prescription, and state rules still apply.

When paying cash makes more sense than fighting UHC

Check your insured estimate before choosing a cash program. Cash-pay telehealth can make sense when your plan excludes the format you and your clinician prefer, your deductible leaves you paying the full allowed charge, or you value the program's stated clinician access. The Male Excel and Hone clinical services discussed below are self-pay; compounded testosterone is not FDA-approved.

This section is not for you if: low testosterone hasn't been properly evaluated yet; you're trying to conceive now or soon; you have a history of prostate or breast cancer, a very high hematocrit (a high share of red blood cells), untreated severe sleep apnea, or a recent heart attack or stroke. Start with primary care, urology, endocrinology or reproductive urology instead. Our page on who should not take TRT explains why. And if your goal is simply to get UHC to pay, go back to the checklist. That's your best move.

Affiliate disclosure: TRT Provider Guide has affiliate relationships with providers, including Male Excel and Hone Health, and may earn a commission from qualifying referrals. The provider links on this page go to their official information pages. That never changes what we report. If getting UHC to pay is your goal, start with your plan and an in-network clinician. Read our affiliate disclosure.

What we actually verified (October 22, 2026)

  • Sources checked: Male Excel's homepage, pricing, testing and terms pages; Hone Health's membership, medication, lab, insurance and cancellation pages; our own TRT providers that take insurance research.
  • Confirmed as published by the provider: Male Excel's consultation/test, membership and starting bundle prices; its no-insurance terms; its excluded-state list; and its compounded-product disclaimer. Hone Health's membership tiers, testing fees, starting medication prices, no-prior-authorization statement and cancellation terms.
  • Provider-stated, not independently tested: clinician access, lab inclusion, refill timing and support quality.
  • Not confirmed: a personal all-in quote; whether Male Excel's startup price includes separate repeat early-morning diagnostic testing; the manufacturer and NDC (product identification number) of Hone's injection for an individual patient; any member's actual results. Provider terms and prices are not independent evidence of care quality.
  • How we review: How We Review TRT Providers separates verified facts, provider-stated facts and our editorial judgment, and adds up complete cost instead of repeating a teaser price.

Male Excel: a cash-pay option with separately billed membership and medication

The numbers (provider-stated, Oct. 22, 2026):

  • Online consultation and initial at-home test: $99, one time, including the advertised blood-spot test and provider consultation
  • Membership: $99/month, covering unlimited e-visits with your provider, unlimited messaging with support staff, and blood testing every six months
  • Medication: advertised testosterone-and-thyroid bundles from $120/month for injectable testosterone or $132/month for cream, billed as a 60-day supply; shipping extra. These are not standalone testosterone-only quotes. A clinician determines which medications are appropriate.
  • 12-month advertised-rate subtotal (injectable bundle): $99 + 12 × ($99 + $120) = $2,727 before shipping, applicable taxes, extra services or prescription changes (our calculation from Male Excel's published prices). Medication is sold in 60-day supplies; confirm the billing dates and number of shipments needed for a full year.
  • Commitment: advertised as no contract; cancel anytime. Previously processed charges and prescriptions remain subject to the refund restrictions in its terms. A separate conditional 90-day guarantee covers membership fees; it is not an all-purchase refund promise.
  • Payment: FSA, HSA or HRA funds may apply
  • Not available in: Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire or Rhode Island

The tradeoff, straight: Male Excel does not bill UnitedHealthcare. If getting UHC to pay is your priority, an in-network doctor prescribing an FDA-approved generic is the better fit. The checklist above helps you prepare that request. For the reader who values the stated access, the tradeoff may still make sense. Its cash-pay charges do not use UHC's authorization process; you pay those charges yourself. Membership and medication have separate charges, with unlimited e-visits and labs every six months built into the membership. Its terms also say the patient and participating lab, medical group and pharmacies will not submit reimbursement claims for these services and products.

Male Excel's testosterone is compounded, and its own disclaimer says it is not FDA-approved. If you require an FDA-approved product, choose a clinician and pharmacy that can provide one; that may be insured or cash-pay.

Before treating that subtotal as your budget: ask whether separate repeat early-morning diagnostic testing is needed and included. We could not establish that from the advertised startup package. The published six-month monitoring benefit does not answer the initial repeat-test question.

Male Excel describes medical assessments and refills every two months. Its FAQ names Anazao Health Corp. and WellDyneRx-FL; its terms require use of contracted pharmacies. Confirm the assigned prescriber, pharmacy and exact product before paying. Its consent permits requested medical-record copies, with reasonable preparation and delivery charges.

Provider sources checked October 22, 2026: pricing, startup testing, FAQ, terms, consent and limited membership guarantee. These establish published terms, not independently tested service quality.

Does that tradeoff fit you? See Male Excel's current pricing and check its published state availability. A clinician still decides whether treatment is right for you.

Hone Health: Basic testing is separate from its TRT memberships

Hone Health lists a Basic membership at $25/month (lab testing every six months and members-only pricing) and a Premium membership at $155/month (advertised quarterly lab testing plus private telehealth visits), with medication billed separately. It says there's no commitment and you can cancel anytime (provider-stated, Oct. 22, 2026). Hone says its clinical services are self-pay and it does not complete prior authorizations. It allows prescriptions to be filled at a local pharmacy, which bills the medication separately; your membership continues, and insurance payment is not guaranteed.

Basic does not include TRT or hormonal prescriptions. Its published fees include a $25 one-time onboarding charge, making $50 due at signup including the first membership month, and an optional $75 men's consultation. Plus, the men's hormone-care tier omitted from the homepage comparison, is $135/month. Its initial test is $45; its pages disagree on the at-lab confirmatory-test charge ($45 versus $50), while listing $80 for an at-home confirmatory test. Premium lists $65 for the initial test and $25 for a TRT confirmatory test. Medication is separate, and the prescribed testing plan may add costs.

Hone's help center lists cypionate from $28 per vial and compounded cream or troches at $60 per month. Its product page instead advertises cypionate from $28 per month. Before you pay, ask Hone two things: the monthly medication price, and whether the prescribed testosterone is FDA-approved or compounded. Confirm the exact product and quantity; the pages checked do not identify the injection's manufacturer or NDC for your prescription.

Membership and prescription orders must be canceled separately. There is no partial-month membership refund, and processed or shipped prescription orders have cancellation and refund restrictions.

For a full-year comparison, 12 membership payments alone are $1,620 for Plus or $1,860 for Premium. Add the initial and confirmatory tests above, your exact medication quote, and any other quoted charges. A vial price is not a monthly treatment cost. Hone advertises free shipping through its service; a local pharmacy's terms are separate.

Hone's TRT follow-up guidance describes testing around 10 weeks, then quarterly during the first year and generally every six months afterward, subject to the clinician's plan. Plus offers home and lab confirmatory testing; Premium's listed startup tests are at a lab. Ask whether the collection method and timing satisfy your clinician's needs and the UHC policy for any request. Do not assume a home kit supplies all the evidence an insurer needs.

Hone lets members view dated lab results and export consult history. Ask about complete-record transfer, the clinician available in your state, and the pharmacy and exact formulation before paying; the public pages checked did not establish an assigned pharmacy or injection manufacturer for an individual patient.

Provider sources checked October 22, 2026: Basic, Plus, Plus lab schedule, Premium, testosterone product pricing, insurance, local-pharmacy policy, follow-up, cancellation and consult-history export.

Want to compare the separate testing and hormone-care options? Compare Hone Health's membership options.

Still weighing insurance against cash? Find My TRT Path offers general online-care guidance. It won't check your UHC benefits, so pair it with the call script above.

What should you settle with your doctor before starting TRT?

Insurance approval doesn't replace a medical evaluation. Before starting, a clinician should confirm the diagnosis, look for a cause, review your health history and set up monitoring. Testosterone can lower sperm production, and the Endocrine Society recommends against starting it in men planning fertility in the near term.

  • Fertility first. Testosterone therapy can reduce spermatogenesis (sperm production). If you want kids soon, tell your doctor before any prescription. A urologist or reproductive urologist may suggest other approaches. Fertility outcomes vary, and nobody can promise you'll keep or recover fertility. See does TRT affect fertility? Fertility-related drugs such as hCG and clomiphene are not TRT, and they have their own coverage rules. Clomiphene use in men is off-label (outside its FDA-approved use); the hCG product Pregnyl has an approved indication for selected cases of hypogonadism caused by pituitary deficiency in males. Neither statement promises fertility preservation or recovery (clomiphene label; Pregnyl label). See hCG cost for men.
  • Monitoring. Expect follow-up testosterone and hematocrit (the share of your blood made of red cells) checks, and PSA (a prostate blood test) when appropriate. See TRT and high hematocrit and TRT and PSA levels.
  • Labels are changing. On June 18, 2026, FDA asked manufacturers to update testosterone labels. The requested changes would remove the long-standing limitation on age-related low testosterone and narrow the prostate-cancer contraindication to metastatic disease (HHS). That announcement alone does not establish the current label for every product or change your plan's coverage criteria. Check the current product label and the policy that applies to your plan; some drug lists also carry age-limit flags.
  • Blood pressure. FDA requires testosterone labels to address blood pressure increases (FDA).

Get emergency care right away for chest pain, trouble breathing, or signs of stroke (face drooping, arm weakness, slurred speech). Get prompt medical care for a painful, swollen leg. See the CDC's guidance on blood-clot symptoms and stroke signs.

How we built this page

This guide is based on UnitedHealthcare, government and clinical-guideline documents checked on October 22, 2026. We verified the published rules and their scope. We did not check any individual member's benefits, submit a claim, or test a real authorization.

UnitedHealthcare testosterone coverage table 12: How we built this page
What we checked What it supports
UHC pharmacy PA program 2025 P 2018-19 (effective Feb. 1, 2026) Initial and renewal pathways, Xyosted product-history rules, 12-month approvals
UHC medical policy 2026D0076J (effective Jan. 1, 2026) Commercial medical-benefit injections, pellets, Aveed, Azmiro, compounded products
UHC Prescription Drug List (effective Sept. 1, 2026) and Optum Rx Premium list (Jan. 1, 2026) Tiers and PA marks in the coverage map
UHC Exchange policy IEXD0076.07 and Community Plan policy CS2026D0076Q Plan-type differences
UHC lab policy 2026R8020A and September 2026 Commercial and Exchange bulletins Lab payment limits and dates
UHC Community Plan drug lists for Maryland and Rhode Island (Oct. 1, 2026) State examples
UHC NC-13/NC-14 example Medicare formulary and appeal page Medicare listing and appeal timelines
DEA, FDA, HHS, Endocrine Society, HealthCare.gov Legal, safety and clinical context
Provider websites (Male Excel, Hone Health) and GoodRx Provider-stated prices and terms

What we didn't do: enroll in a program, call UHC as a member, or have this page reviewed by a clinician. Our method is documented in How We Review TRT Providers. The verification date above applies to this review. Spot something outdated? Use our corrections process. Our editorial standards explain our sourcing, and our privacy policy explains how site information is handled.

UnitedHealthcare and TRT: frequently asked questions

UHC testosterone coverage depends on the member plan, product and applicable policy pathway. These answers summarize the documents checked on October 22, 2026; ask your plan for a written decision on your own request.

Does UnitedHealthcare require prior authorization for testosterone injections?

There is no prior-authorization flag for generic testosterone cypionate or enanthate in UHC's published commercial drug list effective September 1, 2026; both are Tier 1. The January 2026 Optum Rx Premium PA list includes those injections. Check your own plan's current list and any medical-benefit review requirements.

What testosterone level does UHC require for TRT?

The lab-based initial pathway in UHC's pharmacy program asks for two pre-treatment total testosterone results under 300 ng/dL or below the lab's reference range, taken at separate times. For certain conditions that affect SHBG, one qualifying low pre-treatment calculated free or bioavailable testosterone result can count instead. Specified medical histories have a separate pathway. A number alone doesn't diagnose low testosterone. A clinician does.

Does UnitedHealthcare cover AndroGel or testosterone gel?

In the September 2026 published commercial list, the listed generic 1.62% gels are Tier 2 and the 12.5 mg/act 1% gel is Tier 4. Both require prior authorization and have quantity limits. UHC's January 2026 commercial list excluded some gel presentations; check your current list for the exact product.

Does UHC cover Kyzatrex or other oral testosterone?

Kyzatrex is Tier 4 with prior authorization and a quantity limit in the September 2026 published commercial list. Jatenzo, Tlando and Undecatrex are in UHC's prior-authorization program but marked "may be excluded," so your doctor may need a formulary exception.

Does UnitedHealthcare cover Xyosted?

Under the cited pharmacy program's initial hypogonadism pathways, Xyosted requires prior authorization plus documented failure, contraindication or intolerance with both generic injections, generic 1.62% gel and Testim. Your plan must also cover the product or approve an applicable exception.

Does UHC cover testosterone pellets?

FDA-approved Testopel pellets can be covered under UHC's Commercial medical-benefit policy when the criteria are met. That policy treats compounded pellets as unproven and not medically necessary for any indication.

Does UnitedHealthcare cover compounded testosterone cream?

UHC's Commercial medical-benefit policy says compounded hormone products, including compounded testosterone, are not proven or medically necessary for any indication. Compounded testosterone is not FDA-approved.

How long does a UHC testosterone prior authorization last?

The cited pharmacy program issues 12-month approvals. Renewal has a specified-medical-history pathway or a recent-lab pathway. The latter accepts total testosterone, or calculated free/bioavailable testosterone with an SHBG-related condition, from the past 12 months. It must be within or below the reporting lab's normal male range, or above it with a documented dose adjustment; medication conditions also apply to that pathway.

Will UHC cover TRT if I take anastrozole?

Current aromatase-inhibitor use conflicts with the lab-based initial and recent-lab renewal pathways in UHC's pharmacy program for gels, oral capsules or Xyosted. The specified-medical-history pathways are different. Talk to your prescriber. Don't stop or change any medication on your own.

Does UHC cover TRT for fatigue?

Fatigue by itself isn't one of the reasons listed in the lab-based initial pathway of UHC's pharmacy program. The listed reasons include decreased libido, low bone density, significant weight loss and an organic cause. Your doctor documents what you actually have.

Do I have to stop TRT to get UHC to cover it?

UHC's pharmacy program says pre-treatment labs "may require treatment to be temporarily held." Bring your original pre-TRT lab reports if you have them. For medical-benefit treatment, UHC's Commercial policy also has a path for men already on therapy. Never stop testosterone without a clinician.

Does UnitedHealthcare cover testosterone blood tests?

Coverage and your cost depend on your plan. For Commercial and Individual & Family plans, UHC's lab reimbursement policy limits total testosterone during TRT to once every 60 days. It excludes total, free or bioavailable testosterone tests ordered for people with no symptoms or only non-specific ones. These are payment limits, not a personal monitoring schedule.

Does AARP Medicare Advantage cover testosterone?

The 2026 AARP Medicare Advantage NC-13/NC-14 example formulary lists testosterone gel, testosterone cypionate and testosterone enanthate. Tier and prior authorization vary by plan, so check your plan's formulary on myAARPMedicare.com.

Does UnitedHealthcare Community Plan cover TRT?

It depends on your state. UHC's Community Plan policy sends several states to their own Medicaid rules. State drug lists differ, too: in October 2026, Rhode Island required prior authorization for generic cypionate 200 mg/mL, while Maryland showed diagnosis, quantity and age-limit flags.

Can I use UnitedHealthcare with an online TRT clinic?

It depends on the clinic, product and your exact plan. Male Excel does not bill insurance; Hone's clinical services are self-pay, but it permits local-pharmacy prescriptions and does not handle prior authorization. Some programs say HSA or FSA funds may apply. Ask the clinic whether it's in network for your exact plan before you pay.

Will UHC reimburse a cash clinic's membership fee?

Don't assume it will. Ask UHC about the exact service and provider before paying. A receipt from a clinic is not a coverage decision.

Not automatically. In June 2026, FDA asked manufacturers to update testosterone labels, including removing the age-related limitation. That's a request, not a coverage decision. Your plan's current criteria still control; the Maryland example on this page also carries age-limit flags.

What if my testosterone treatment is for gender-affirming care?

UHC's policies have a separate gender-dysphoria pathway with its own criteria, and coverage can depend on your plan's benefit design. The adult male hypogonadism rules on this page don't apply. Ask UHC for the policy that matches your care.

Before you pay: UnitedHealthcare can cover TRT when your plan covers the requested product and the applicable criteria are met. Bring the records for your pathway, a complete and accurate medication list, and the exact product details. Get the full insured quote, then compare it with the cash options. The checklist and cost worksheet above give you a way to do that.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

This page is educational information, not medical advice. Your clinician decides what care is appropriate, and your plan decides benefits under its terms.

Sources

Ready to explore your options?

Our tool helps you narrow down the care route that fits your situation based on testing, budget, and fertility goals.

Find My TRT Path

Not sure which TRT route fits you?

Find My TRT Path